The mechanism of SGLT2 inhibition in glucose control - PACE-CME

The mechanism of SGLT inhibition in glucose control

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
AHA 2024
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
- Shawna Nesbitt, MD
Screening for CKM syndrome
Screening for CKM syndrome
MinuteCE®
Screening for CKM syndrome
1.00 program credit
- Jürgen Floege, MD
1.00 program credit
Case-based learning and future directions
Case-based learning and future directions
MinuteCE®
Case-based learning and future directions
1.00 program credit
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
- Muthiah Vaduganathan, MD, MPH
- Jurgen Floege MD
1.00 program credit
MinuteCE®
Optimizing care for patients with CKM syndrome: a multidisciplinary approach
1.00 credit 4 episodes
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
- Jürgen Floege, MD
- Muthiah Vaduganathan, MD, MPH
1.00 credit 4 episodes